SynthesisESC heart failure2025
Aortic stenosis intricacies beyond the valve: A bidirectional Mendelian randomization study.
Synthesis in ESC heart failure, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 1 synthesis or guideline pooled it.
- Aortic stenosis intricacies beyond the valve: A bidirectional Mendelian randomization study.ESC heart failure · 2025Pooled it
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
aimsNumerous observational studies have reported an association between calcific aortic valve stenosis (CAVS) and an increased risk of other cardiovascular diseases (CVDs). However, the potential causal association is uncertain. METHODS AND
resultsA bidirectional Mendelian randomization (MR) analysis was performed to confirm the causal association between CAVS and the risk of seven common CVDs. The meta-analysis was used to estimate the combined causal effect with multiple MR results. The MR analysis indicated that genetically predicted CAVS is associated with the increased risk of heart failure (odds ratio [OR] = 1.064; 95% confidence interval [CI] [1.008, 1.123]; P = 0.025), large-artery stroke (OR = 1.256; 95% CI [1.112, 1.418]; P < 0.001), cardioembolic stroke (OR = 1.228; 95% CI [1.117, 1.349]; P < 0.001) and atrial fibrillation (OR = 1.100; 95% CI [1.061, 1.140]; P < 0.001) without heterogeneity and pleiotropy. Genetically predicted hypertension (FinnGen: OR = 1.170; 95% CI [1.055, 1.297]; P = 0.003 and UK Biobank: OR = 2.456; 95% CI: 1.571, 3.840; P = 8.16 × 10
conclusionsThis comprehensive MR study revealed the causal relationship between genetically predicted CAVS and the increased risk of various CVDs and the causal relationship between hypertension and CAVS risk. Given the harmful causal impact of CAVS on adverse cardiovascular events, it is crucial to prioritize the prevention and management of CVD in individuals with CAVS. Blood pressure management is an effective preventive intervention.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.